<?xml version="1.0" encoding="UTF-8"?>
<p>Patients with suspicious PCa and had no previous biopsy will be considered eligible for registration in this trial if they can meet all inclusion criteria and had no any exclusion criteria. The main criteria include men with elevated serum PSA above 4â€“20 ng/mL or with an abnormal DRE and have never had a biopsy before. The details of inclusion and exclusion criteria are shown in 
 <xref ref-type="boxed-text" rid="B1">box 1</xref>. All eligible patients will be informed in detail, and only those who sign the consent form can participate in the trial. Men who are ineligible or do not want to participate in the study will be returned to the regular clinical pathway.
</p>
